Kinetics of erythrocyte lithium-sodium countertransport in patients with affective illness before and during lithium therapy

Jay D. Amsterdam, Janusz Rybakowski, Janice Gottlieb, Alan Frazer

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Previous investigations have elucidated an erythrocyte lithium-sodium countertransport (LSC) system as the primary mechanism for extruding lithium from the cell, and this activity has been described in terms of Michaelis-Menten kinetics. In most clinical studies the maximum velocity (Vmax) of the LSC has been measured by estimating the rate of lithium efflux from lithium-loaded cells. To date, few studies have examined whether the affinity (Km) of the LSC for lithium might be altered in patients with affective disorders. In the present study we examined LSC kinetic parameters (Vmax, leak Km, and in vitro lithium ratio) at baseline in 80 patients with affective disorder and 25 healthy control subjects, and after 6 weeks of lithium administration in 33 of the patients. No differences in Vmax were observed between any patient and control group, although Vmax was significantly lower in unipolar depressed men compared to bipolar men (P=0.043). The affinity (Km) of the transport 'carrier' for lithium did not differentiate between patient and control groups. Chronic lithium administration caused a decreased Vmax in bipolar men (P=0.015), an increase in the in vitro lithium ratio in bipolar men (P=0.002) and bipolar women (P=0.002), and a marginal increase in Km in bipolar men (P=0.08) and bipolar women (P=0.06). Although the present data do not demonstrate an underlying difference for Km between affectively ill patients and controls, they do indicate a decrease in the affinity of the transport 'carrier' for lithium after chronic lithium administration.

Original languageEnglish (US)
Pages (from-to)75-81
Number of pages7
JournalJournal of Affective Disorders
Volume14
Issue number1
DOIs
StatePublished - 1988
Externally publishedYes

Fingerprint

Lithium
Erythrocytes
Sodium
Therapeutics
Mood Disorders
Control Groups
Healthy Volunteers

Keywords

  • Affective disorder
  • Lithium therapy
  • Lithium-sodium countertransport

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Behavioral Neuroscience
  • Biological Psychiatry
  • Neurology
  • Psychology(all)

Cite this

Kinetics of erythrocyte lithium-sodium countertransport in patients with affective illness before and during lithium therapy. / Amsterdam, Jay D.; Rybakowski, Janusz; Gottlieb, Janice; Frazer, Alan.

In: Journal of Affective Disorders, Vol. 14, No. 1, 1988, p. 75-81.

Research output: Contribution to journalArticle

@article{777835e49f9649fabfa6d0f59f14ff68,
title = "Kinetics of erythrocyte lithium-sodium countertransport in patients with affective illness before and during lithium therapy",
abstract = "Previous investigations have elucidated an erythrocyte lithium-sodium countertransport (LSC) system as the primary mechanism for extruding lithium from the cell, and this activity has been described in terms of Michaelis-Menten kinetics. In most clinical studies the maximum velocity (Vmax) of the LSC has been measured by estimating the rate of lithium efflux from lithium-loaded cells. To date, few studies have examined whether the affinity (Km) of the LSC for lithium might be altered in patients with affective disorders. In the present study we examined LSC kinetic parameters (Vmax, leak Km, and in vitro lithium ratio) at baseline in 80 patients with affective disorder and 25 healthy control subjects, and after 6 weeks of lithium administration in 33 of the patients. No differences in Vmax were observed between any patient and control group, although Vmax was significantly lower in unipolar depressed men compared to bipolar men (P=0.043). The affinity (Km) of the transport 'carrier' for lithium did not differentiate between patient and control groups. Chronic lithium administration caused a decreased Vmax in bipolar men (P=0.015), an increase in the in vitro lithium ratio in bipolar men (P=0.002) and bipolar women (P=0.002), and a marginal increase in Km in bipolar men (P=0.08) and bipolar women (P=0.06). Although the present data do not demonstrate an underlying difference for Km between affectively ill patients and controls, they do indicate a decrease in the affinity of the transport 'carrier' for lithium after chronic lithium administration.",
keywords = "Affective disorder, Lithium therapy, Lithium-sodium countertransport",
author = "Amsterdam, {Jay D.} and Janusz Rybakowski and Janice Gottlieb and Alan Frazer",
year = "1988",
doi = "10.1016/0165-0327(88)90074-2",
language = "English (US)",
volume = "14",
pages = "75--81",
journal = "Journal of Affective Disorders",
issn = "0165-0327",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Kinetics of erythrocyte lithium-sodium countertransport in patients with affective illness before and during lithium therapy

AU - Amsterdam, Jay D.

AU - Rybakowski, Janusz

AU - Gottlieb, Janice

AU - Frazer, Alan

PY - 1988

Y1 - 1988

N2 - Previous investigations have elucidated an erythrocyte lithium-sodium countertransport (LSC) system as the primary mechanism for extruding lithium from the cell, and this activity has been described in terms of Michaelis-Menten kinetics. In most clinical studies the maximum velocity (Vmax) of the LSC has been measured by estimating the rate of lithium efflux from lithium-loaded cells. To date, few studies have examined whether the affinity (Km) of the LSC for lithium might be altered in patients with affective disorders. In the present study we examined LSC kinetic parameters (Vmax, leak Km, and in vitro lithium ratio) at baseline in 80 patients with affective disorder and 25 healthy control subjects, and after 6 weeks of lithium administration in 33 of the patients. No differences in Vmax were observed between any patient and control group, although Vmax was significantly lower in unipolar depressed men compared to bipolar men (P=0.043). The affinity (Km) of the transport 'carrier' for lithium did not differentiate between patient and control groups. Chronic lithium administration caused a decreased Vmax in bipolar men (P=0.015), an increase in the in vitro lithium ratio in bipolar men (P=0.002) and bipolar women (P=0.002), and a marginal increase in Km in bipolar men (P=0.08) and bipolar women (P=0.06). Although the present data do not demonstrate an underlying difference for Km between affectively ill patients and controls, they do indicate a decrease in the affinity of the transport 'carrier' for lithium after chronic lithium administration.

AB - Previous investigations have elucidated an erythrocyte lithium-sodium countertransport (LSC) system as the primary mechanism for extruding lithium from the cell, and this activity has been described in terms of Michaelis-Menten kinetics. In most clinical studies the maximum velocity (Vmax) of the LSC has been measured by estimating the rate of lithium efflux from lithium-loaded cells. To date, few studies have examined whether the affinity (Km) of the LSC for lithium might be altered in patients with affective disorders. In the present study we examined LSC kinetic parameters (Vmax, leak Km, and in vitro lithium ratio) at baseline in 80 patients with affective disorder and 25 healthy control subjects, and after 6 weeks of lithium administration in 33 of the patients. No differences in Vmax were observed between any patient and control group, although Vmax was significantly lower in unipolar depressed men compared to bipolar men (P=0.043). The affinity (Km) of the transport 'carrier' for lithium did not differentiate between patient and control groups. Chronic lithium administration caused a decreased Vmax in bipolar men (P=0.015), an increase in the in vitro lithium ratio in bipolar men (P=0.002) and bipolar women (P=0.002), and a marginal increase in Km in bipolar men (P=0.08) and bipolar women (P=0.06). Although the present data do not demonstrate an underlying difference for Km between affectively ill patients and controls, they do indicate a decrease in the affinity of the transport 'carrier' for lithium after chronic lithium administration.

KW - Affective disorder

KW - Lithium therapy

KW - Lithium-sodium countertransport

UR - http://www.scopus.com/inward/record.url?scp=0023829845&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023829845&partnerID=8YFLogxK

U2 - 10.1016/0165-0327(88)90074-2

DO - 10.1016/0165-0327(88)90074-2

M3 - Article

C2 - 2828448

AN - SCOPUS:0023829845

VL - 14

SP - 75

EP - 81

JO - Journal of Affective Disorders

JF - Journal of Affective Disorders

SN - 0165-0327

IS - 1

ER -